annual cash & cash equivalents:
$344.87M-$13.46M(-3.76%)Summary
- As of today (September 16, 2025), KRYS annual cash & cash equivalents is $344.87 million, with the most recent change of -$13.46 million (-3.76%) on December 31, 2024.
- During the last 3 years, KRYS annual cash & cash equivalents has risen by +$3.62 million (+1.06%).
- KRYS annual cash & cash equivalents is now -3.76% below its all-time high of $358.33 million, reached on December 31, 2023.
Performance
KRYS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$681.99M+$65.14M(+10.56%)Summary
- As of today (September 16, 2025), KRYS quarterly cash & cash equivalents is $681.99 million, with the most recent change of +$65.14 million (+10.56%) on June 30, 2025.
- Over the past year, KRYS quarterly cash & cash equivalents has increased by +$122.37 million (+21.87%).
- KRYS quarterly cash & cash equivalents is now at all-time high.
Performance
KRYS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KRYS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.8% | +21.9% |
| 3 y3 years | +1.1% | +60.3% |
| 5 y5 years | +83.9% | +129.5% |
KRYS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.8% | +113.0% | at high | +94.6% |
| 5 y | 5-year | -3.8% | +113.0% | at high | +151.4% |
| alltime | all time | -3.8% | >+9999.0% | at high | >+9999.0% |
KRYS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $681.99M(+10.6%) |
| Mar 2025 | - | $616.85M(+3.2%) |
| Dec 2024 | $344.87M(-3.8%) | $597.52M(+1.6%) |
| Sep 2024 | - | $588.32M(+5.1%) |
| Jun 2024 | - | $559.61M(+4.0%) |
| Mar 2024 | - | $538.26M(+1.1%) |
| Dec 2023 | $358.33M(+121.3%) | $532.18M(-5.3%) |
| Sep 2023 | - | $562.07M(+17.7%) |
| Jun 2023 | - | $477.52M(+36.3%) |
| Mar 2023 | - | $350.39M(-7.6%) |
| Dec 2022 | $161.90M(-52.6%) | $379.17M(-3.9%) |
| Sep 2022 | - | $394.42M(-7.3%) |
| Jun 2022 | - | $425.56M(-2.1%) |
| Mar 2022 | - | $434.63M(-0.8%) |
| Dec 2021 | $341.25M | $438.10M(+27.7%) |
| Sep 2021 | - | $343.09M(-6.7%) |
| Jun 2021 | - | $367.73M(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $403.42M(+48.7%) |
| Dec 2020 | $268.27M(+43.1%) | $271.26M(-5.3%) |
| Sep 2020 | - | $286.37M(-3.6%) |
| Jun 2020 | - | $297.17M(+59.2%) |
| Mar 2020 | - | $186.70M(-3.6%) |
| Dec 2019 | $187.51M(+80.9%) | $193.69M(-4.7%) |
| Sep 2019 | - | $203.21M(+4.0%) |
| Jun 2019 | - | $195.47M(+83.3%) |
| Mar 2019 | - | $106.63M(-4.6%) |
| Dec 2018 | $103.67M(+109.1%) | $111.76M(+113.7%) |
| Sep 2018 | - | $52.29M(+15.1%) |
| Jun 2018 | - | $45.45M(-3.8%) |
| Mar 2018 | - | $47.23M(-4.8%) |
| Dec 2017 | $49.59M(+2478.8%) | $49.59M(-5.7%) |
| Sep 2017 | - | $52.57M(+1394.3%) |
| Jun 2017 | - | $3.52M(+79.6%) |
| Mar 2017 | - | $1.96M(+1.9%) |
| Dec 2016 | $1.92M | $1.92M |
FAQ
- What is Krystal Biotech, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. annual cash & cash equivalents year-on-year change?
- What is Krystal Biotech, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. quarterly cash & cash equivalents year-on-year change?
What is Krystal Biotech, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of KRYS is $344.87M
What is the all time high annual cash & cash equivalents for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high annual cash & cash equivalents is $358.33M
What is Krystal Biotech, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, KRYS annual cash & cash equivalents has changed by -$13.46M (-3.76%)
What is Krystal Biotech, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of KRYS is $681.99M
What is the all time high quarterly cash & cash equivalents for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high quarterly cash & cash equivalents is $681.99M
What is Krystal Biotech, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, KRYS quarterly cash & cash equivalents has changed by +$122.37M (+21.87%)